Based on your new understanding of biological cybersecurity, identify possible ethical considerations and explain your position.
When it comes to something like genetic modification, there need to be some serious ethical considerations in place if this procedure becomes commonplace. One of those considerations would be the need for gene modification in certain situations. Gene editing isn’t necessarily the answer for every single medical issue. Another consideration is the possible risks that may come with the procedure. It may not be possible to get informed consent for a procedure like this because the risks for it may differ from person to person. A final consideration could be how editing the genetic makeup of humans could be leaning toward eugenics. While experts in the medical field may deem the concept safe despite the relation, the general public may not see gene editing that way and may relate it to the more harmful idea of eugenics.
My position on gene editing is complicated. On one hand, it could pave the way for eliminating genetic disorders and could help the medical field immensely. But it could also lead to companies asking for people’s genetic data to see if they objectively qualify for a job. People may be forced to undergo gene editing for certain careers, but it could also create societal ostracism based on people’s DNA. The economy could also take an impact if gene editing end’s up creating a bigger wage gap. There’s also the possibility of your DNA being stolen or sold somewhere if it isn’t secured well. If companies and organizations that house that research and information don’t have the greatest security measures, then it could create massive problems for people’s identities. To reiterate, while I think genetic editing has its positives, it comes with a multitude of risks that may hold it back from being commonplace for quite some time.
https://drive.google.com/file/d/1tJfWKjsY04Tha9QLZK0TJHd4U_m6JDxV/viewLinks to an external site.
Joung, J., Sander, J. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol14, 49–55 (2013). https://doi.org/10.1038/nrm3486Links to an external site.
Memi, F., Ntokou, A., & Papangeli, I. (2018). CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations. Seminars in Perinatology, 42(8), 487-500. https://doi.org/10.1053/j.semperi.2018.09.003Links to an external site.https://drive.google.com/file/d/17vZTrd3tyRkIuXtLfYKSeZypU7WpCkmM/viewLinks to an external site.
Silva, G., Poirot, L., Galetto, R., Smith, J., Montoya, G., Duchateau, P., & Pâques, F. (2011). Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy. Current Gene Therapy, 11(1), 11-27. https://doi.org/10.2174/156652311794520111Links to an external site.